Physician
James Shortridge, DO
According to 2025 Medicare claims, James Shortridge, DO (NPI: 1205148061) practices hematology/oncology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is UTAH CANCER SPECIALISTS PC (NPI: 1619925369; TIN: 870519691) and primary practice location at 84088-8858.
Shortridge's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 297 traditional Medicare patients, billed 78,139 HCPCS/CPT codes, and received $1,680,868 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,210 prescription claims across 215 beneficiaries totaling $7,563,234 in drug costs, led by Revlimid (Lenalidomide). DME data shows 76 claims. Open Payments data shows 57 records totaling $1,545. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $170,880 to $1,680,868. Similarly, Part D prescription costs have moved sharply higher in recent years, from $63,040 to $7,563,234. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.